Xy Capital LTD Hutchmed (China) LTD Transaction History

Xy Capital LTD

  • $292 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023
BUY
$10.78 - $17.73 $161,322 - $265,329
14,965 Added 129.57%
26,515 $318 Million
Q1 2023

May 08, 2023
BUY
$13.02 - $19.87 $8,293 - $12,657
637 Added 5.84%
11,550 $150 Million
Q4 2022

Feb 09, 2023
BUY
$7.65 - $15.51 $83,484 - $169,260
10,913 New
10,913 $161 Million

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Xy Capital LTD Portfolio

Follow Xy Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xy Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xy Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email